# Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer

> **NCT04840472** · PHASE1 · SUSPENDED · sponsor: **Stanford University** · enrollment: 28 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** 111I-n panitumumab
- **PROCEDURE:** Single photon emission computed tomography/computed tomography (SPECT/CT) scans

## Key facts

- **NCT ID:** NCT04840472
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-03-30
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 28 (ESTIMATED)
- **Why stopped:** tentatively suspended until drug manufacturing is available
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04840472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04840472, "Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04840472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*